Tirzepatide (Zepbound) was effective at reducing body weight in Chinese adults with lower cutoffs for overweight or obesity, the SURMOUNT-CN trial reported. In the study of 210 adults without diabetes ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results